Pictet Asset Management (UK)’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | $26M | Buy |
744,897
+47,379
| +7% | +$1.66M | 0.03% | 467 |
|
2021
Q1 | $23.2M | Sell |
697,518
-385,899
| -36% | -$12.9M | 0.03% | 474 |
|
2020
Q4 | $28.1M | Sell |
1,083,417
-877,725
| -45% | -$22.8M | 0.04% | 418 |
|
2020
Q3 | $19.4M | Buy |
1,961,142
+201,185
| +11% | +$1.99M | 0.03% | 431 |
|
2020
Q2 | $6.07M | Hold |
1,759,957
| – | – | 0.01% | 637 |
|
2020
Q1 | $5.39M | Buy |
1,759,957
+24,124
| +1% | +$73.8K | 0.01% | 621 |
|
2019
Q4 | $8.92M | Buy |
1,735,833
+251,961
| +17% | +$1.3M | 0.02% | 600 |
|
2019
Q3 | $7.66M | Buy |
1,483,872
+1,452,172
| +4,581% | +$7.49M | 0.02% | 579 |
|
2019
Q2 | $192K | Buy |
+31,700
| New | +$192K | ﹤0.01% | 989 |
|